Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
Federal Reserve Vice Chair Richard Clarida said Friday that the global economy has deteriorated in the past month.Marketsread more
The latest escalation in the trade war ups the odds the economy will fall into recession and that the Fed will aggressively cut rates.Market Insiderread more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
"We don't need China and, frankly, would be far better off without them," Trump tweeted.Politicsread more
"My only question is, who is our bigger enemy, Jay Powell or Chairman Xi?" Trump wrote amid a series of tweets that rattled markets Friday.Politicsread more
"I would love this to be clarified. We come to a deal on trade, boy, this market is up 10 to 15%, but without it's going to be worrisome," Jeremy Siegel says.Marketsread more
The final week of August could be highly volatile as markets fret over the economy and the latest developments in trade wars.Market Insiderread more
Tesla solar energy systems reportedly ignited at an Amazon warehouse in Redlands, California last June, and the Seattle e-commerce titan confirmed that it has no further plans...Technologyread more
The death comes as federal and state health officials investigate a slew of lung illnesses in connection to e-cigarette use.Health and Scienceread more
But Auris Medical isn't the company being bought by J&J. Auris Health is.
Investors (and computer algorithms) mistakenly bought shares of Auris Medical instead of Auris Health, a robotic surgery company. This was actually the second time that Auris Medical has gotten a surprise boost. The stock jumped more than 30 percent on Jan.23 when news came out that J&J was pursuing a deal with Auris Health.
Auris Medical has a tiny market value of $12 million and is based in Zug, Switzerland. It makes treatment inner ear ailments.
Auris Health is a privately held company and doesn't have shares available for secondary trading.
The mistake flies in the face of investors who argue the stock market is efficient and becoming smarter because of the prevalence of computer trading.